Originally featured in on March 1, 2026.

Is the medical device community on the verge of a new paradigm of in vivo shape memory devices? Much like self-expanding superelastic implantable medical devices revolutionized the industry more than 30 years ago, a new stage is being set. The emergence of miniature leadless pacemakers with sealed power supplies that last multiple years, pulsed field ablation for controlled in vivo heating, and brain computer interfaces with complex bioelectronics all demonstrate the rapidly evolving landscape where implantable power/heat sources are on the verge of becoming commonplace. These advancements in implantable power management may very well usher in a wave of shape memory medical devices that require heat activation.

EARLY MEDICAL-DEVICE DESIGN

Some early medical devices such as the Memotherm Stent and Simon Nitinol IVC Filter were marketed as having shape memory. These devices were tuned with an austenitic finish temperature, A_f, above room temperature and below body temperature (e.g., A_f = 30 卤 5掳C). While these devices feel malleable when handled at room temperature and take on a predefined shape at body temperature, thus the perception by users as having 鈥渟hape memory,鈥� they more accurately fall under the category of self-expanding superelastic implants. Instead, a true shape memory implant is one in which a predefined shape is achieved through the application of heat while the device is in its target location in the human body (i.e., austenitic start temperature, A_s, or R-phase start temperature, R_S, is > 37掳C and the device takes on a new shape when heated above body temperature). With the exception of a few benign prostatic hyperplasia implants that rely upon a warm 55-60掳C saline flush to achieve full expansion during implantation (e.g., Memokath, Endocare Horizon Stent), no commercial devices exist that truly utilize the shape memory properties of Nitinol.

A primary obstacle to the use of the shape memory effect in medical devices is the sensitivity of human tissue to damage at relatively low temperatures and short durations. Indeed, tissue damage occurs after just 1 second of exposure to 70掳C (Fig. 1). Common binary Nitinol alloy formulations that would seem desirable for in vivo actuation (e.g., Fort Wayne Metals Niti#6 with an A_s 鈮� 35掳C) require temperatures as high as 90掳C to achieve complete actuation above the A_f temperature. Therefore, exceedingly short-duration heating of conventional binary nickel-titanium, or the development of narrower hysteresis ternary/quaternary shape memory alloys may be required for the advancement of shape memory implants.

Fig. 1 鈥� Tissue necrosis time versus temperature curve; adapted from Moritz & Henriques with the red portion of the graph extrapolated to 90掳C consistent with the A_f temperature of common binary Nitinol in vivo shape memory material[1].

NEW PARADIGM

While few commercial implants have used shape memory actuation to date, the aforementioned advancements in implantable power and bioelectronics have inspired a new paradigm. Are these advancements capable of driving the heat-actuation times down to a realm that is safe for surrounding tissue? Three examples of devices currently under development suggest that the answer is 鈥測es.鈥�

Glaucoma is caused by elevated pressures due to fluid buildup in the eye. When pharmaceutical treatments fail, ophthalmologists often turn to implantable shunts to drain fluid from the eye and relieve this pressure (e.g., Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant). Myra Vision鈥檚 novel shape memory implant, the CalibrEye System, offers an adjustable fluid outflow that can be tailored to a patient鈥檚 dynamic needs as their glaucoma advances. Unlike existing shunts with a fixed drainage flow, the CalibrEye device can double or triple its fluid flow by opening two optional drainage channels that are capped by shape memory Nitinol actuators. Selectively heating the innermost arm of each actuator triggers the cap to open the optional drainage channel, and activating the outermost arm closes the cap (Fig. 2). Atraumatic heating of the Nitinol actuators is achieved using a common green laser system mounted on an ophthalmic slit lamp. Although temperatures of approximately 90掳C are required to actuate the device, tissue damage is prevented due to the highly localized spot size (200 碌m) that engages only the Nitinol implant, and the incredibly short pulse duration (100 ms).

Fig. 2 鈥� The CalibrEye glaucoma shunt provides one primary and two secondary (optional) drainage channels for the management of eye pressure. Two independent thin-film shape memory Nitinol actuators provide caps to the optional channels. When green laser energy activates either of these actuators, the cap moves to an open or closed position to optionally increase or decrease fluid flow from the eye through the secondary drainage channels. Adapted from Chang[2].

Recent innovations suggest that a reduction of heart failure symptoms may be achieved by artificially creating a hole in the atrial septum to shunt blood from the left atrium to the right atrium thereby reducing arterial pressure and fluid load (e.g., Corvia Medical, V-Wave Medical, NoYA Medical, and Adona Medical). Interestingly, two interatrial shunt device companies independently arrived at novel shape memory solutions.

Citing the clinical need that 鈥淎 flexible shunt size may help meet the specific or changing requirements of individual patients,鈥� Dr. Neal Eigler posed the question 鈥淲hat if a shunt鈥檚 orifice could be serially adjusted (larger or smaller) in vivo?鈥�[3] Dr. Eigler then introduced the V-Wave Magical shunt as a solution where the proximal and distal conical anchoring ends of the device remained superelastic while the waist of the shunt underwent a selective thermomechanical treatment to locally tune the A_f to 鈮� 60掳C (Fig. 3). This waist region is manufactured such that the shunt diameter would be smallest when heated above the transition temperature, and deformable at body temperature. In such a configuration, the waist can be enlarged to 9.2 mm via a balloon. To shrink the waist, a warm saline flush actuates the device and reduces the diameter to 4.8 mm. This mechanism of ballooning and saline flushing provides physicians with familiar and established techniques that offer bidirectional movement of a Nitinol device in vivo rather than the unidirectional self-expanding mechanism used in the prior decades.

Fig. 3 鈥� V-Wave Ventura device (similar to the Magical device) showing the conical inlet and outlet features of the implant. These superelastic features anchor the device to the patient鈥檚 atrial septum. The waist region is locally tuned to render its shape memory property(i.e., A_s > 37掳C). With this pretrained shape, the waist is malleable and expandable via a balloon at body temperature, and can be contracted to its original small diameter when warm saline is flushed through the device.

Developed in parallel, Adona Medical鈥檚 Delphi shunt operates on a shape memory principle similar to the V-Wave Magical device. However, unlike the Magical device that uses warm saline, which may risk temperature elevation to adjacent tissue, Adona鈥檚 implant uses in vivo induction heating of an electrically and thermally insulated shape memory Nitinol orifice to adjust the shunt diameter without risking a local temperature rise to surrounding tissue[4,5]. Adona鈥檚 first-in-human trial successfully demonstrated atraumatic in vivo actuation of their shunt even months after implantation. Importantly, the Adona team envisioned methods whereby bidirectional actuation could be achieved remotely using ex vivo induction heating coils. By nesting two actuators preset to either a small or large size, and by tuning them to respond to different radio frequencies (RF) for heat induction, each of the actuators operate independently to drive the shunt diameter to any desired size by applying the RF signal external to the patient鈥檚 chest (Fig. 4).

Fig. 4 鈥� Adona Medical鈥檚 nested actuator design enables bidirectional actuation within a single device. Two shape memory implants with a preset cylindrical shape and conical shape are thermally isolated from one another, nested, and joined such that they achieve a stable neutral position between a cylindrical and conical shape. When the outer ring (the cylindrical shape) is heated, e.g., by joule heating through an electrical circuit, the composite structure widens to its dilated position, and vice versa when the inner ring (the conical shape) is heated. Adapted from Alexander et al.[6].

It remains unknown if any of the previously mentioned investigational devices will achieve regulatory approval and commercial success. Regardless, they serve to inspire the next generation of medical-device designers to explore shape memory for innovative Nitinol implants.

Early concepts such as removal of implants days/months/years after implantation by shape memory shrinking them back to catheter size or articulated robotic arms for remote surgery that have since been abandoned in favor of mechanical pull-wire mechanisms may now be worth revisiting in the modern era[7,8]. Arguably, the most impactful opportunity for shape memory innovation is in the field of pediatric devices where the patient鈥檚 size (and hence target therapeutic size of the implant) changes substantially throughout their lifetime. Are these size modifications achievable through unique shape memory actuator designs that eliminate traumatic surgeries currently performed to remove obsolete devices and replace them with upsized implants as the child matures to adulthood?

CHALLENGES AND OPPORTUNITIES

Several challenges (i.e., opportunities for innovation) lie ahead for designers wishing to use shape memory for implantable devices:

• Can binary Nitinol, with its established biocompatibility and regulatory pathway, provide the necessary actuation movements and/or forces using times and temperatures below which would traumatize human tissue?
• If ternary or quaternary alloys are pursued to overcome temperature limitations (e.g., NiTiCu with its very narrow temperature hysteresis) what are the biocompatibility and consequent regulatory challenges for those alloys that haven鈥檛 historically been proven in vivo?
• Manufacturing techniques must be developed to selectively tailor regions of a device to be shape memory while retaining regions of superelasticity elsewhere in the same implant such as that developed by the V-Wave Medical team.
• What methods of heat delivery (e.g., warm saline, induction heating, joule heating) will be available to safely deliver the power required to trigger in-vivo actuation?

Self-expandable superelastic devices have evolved from the humble beginnings of simple wire-form stents into the complex laser-cut metal/polymer/tissue composite heart valves that are commonplace today. Having been involved in the emerging field of shape memory implants and given the recent advancements in bioelectronics as well as power supply miniaturization, this author is optimistic that the industry is at a similar entry point of exponential growth for in vivo actuatable shape memory devices that are beyond current imagination.

Note: The V-Wave Magical and the V-Wave Ventura are registered trademarks of Johnson & Johnson.

For more information: Scott Robertson, Vice President of Nitinol Technology, scottrobertson@resonetics.com

REFERENCES

1. R. Moritz and FC Henriques, Jr., The Relative Importance of Time and Surface Temperature in the Causation of Cutaneous Burns, The American Journal of Pathology, 23(5) p 695-720, September 1947.
2. Chang, Myra Vision CalibEye System, Ophthamology Innovation Summit 2023, slides and presentation accessed 1.8.2026 at .
3. Eigler, Precision Interatrial Shunting鈥atching the Device to the Patient, Innovations in Cardiovascular Interventions meeting; December 6, 2022.
4. Hammerand, Shunt Device Startup Wants to Break Barriers in Nitinol and Heart Sensing, Medical Design & Outsourcing, August 15, 2023, www.medicaldesignandoutsourcing.com/adona-medical-adjustable-heart-shunt-nitinol-biatrial-pressure-sensing.
5. Hammerand, This Shifamed Startup Shares the Shape Memory Secret Behind its Nitinol Heart Failure Implant, Medical Design & Outsourcing, December 1, 2025, www.medicaldesignandoutsourcing.com/adona-medical-shape-memory-nitinol-heart-failure-adjustable-shunt.
6. Alexander, S. Robertson, et al., Shape Memory Actuators for Adjustable Shunting Systems, and Associated Systems and Methods, US 12,090,290 B2, United States Patent and Trademark Office, September 17, 2024.
7. E. Bramfitt and R.L. Hess, A Novel Heat Activated Recoverable Temporary Stent (HARTS System); Shape Memory and Superelastic Technologies Conference 1994.
8. Dario, M.C. Montesi, Shape Memory Alloy Microactuators for Minimal Invasive Surgery, Shape Memory and Superelastic Technologies Conference 1994.

The post Advancements in Shape Memory Implantable Medical Devices appeared first on Driving Innovation in MedTech & Life Sciences.

Originally featured in on August 25, 2025.

The听nitinol听supply chain for medical devices is undergoing a profound transformation. Recent years have seen material shortages, consolidation among suppliers, exclusivity agreements, and access constraints that have forced both tubing producers and device OEMs to reevaluate sourcing strategies. Then add on the challenges posed by global disruptions in recent years, from COVID-19 to climate change to fluctuating inventory levels. It has all exposed vulnerabilities in traditional supply models, prompting manufacturers to seek secure and reliable alternatives.

91快活林鈥� approach

In the past, nitinol supply chains often involved multiple handoffs between melt shops, hollow producers, and tube processors. Think complexity, cost, and the potential for delay.

At听91快活林, we control each step internally, from melting through tubing fabrication. The result for our customers is unmatched consistency, speed, and supply security.

91快活林 has invested in expanding its melt capacity and recently brought gun drilling operations in-house following the acquisition of Medical Components Specialists鈥� gun drilling capabilities and equipment. These moveshave reduced reliance on external processors and ensured production remains closely aligned with customer timelines. Inventory buffers and Kanban systems at every major step allow us to respond rapidly to market needs

It鈥檚 about keeping the flow steady, even when external factors threaten to disrupt supply.

Independence and flexibility

Unlike some competitors tied to exclusive supply arrangements or consortia, 91快活林 operates independently. This independence translates into direct access to ingot and melt capacity without the constraints of exclusivity. Our approach provides a path that is secure, U.S.-based, and designed for medical device OEMs.

Strategic advantages for OEMs

For medical device companies, the benefits of vertical integration are tangible. Working with a single supplier from melt, finished tube, and even component streamlines coordination, eliminates supplier risk, and clarifies costs by avoiding the margin stacking common to multi-party supply chains.

At 91快活林, we鈥檝e been successfully providing ingot to the medical device industry for over 35 years. History matters, and the trust we鈥檝e built with regulators mean that ourcustomers can better navigate qualification barriers for new programs.

Conclusion

The nitinol supply chain landscape will continue to advance, and 91快活林鈥� advantage is that we have a fully integrated model that prioritizes quality, control, and capacity. For engineers, sourcing managers, and executives seeking a secure path forward, the company offers not just a different supply chain, but a smarter, more resilient one.

The post The Power of an Integrated Nitinol Supply Chain appeared first on Driving Innovation in MedTech & Life Sciences.

Originally featured in  on July 23, 2025.

This year,听91快活林听celebrates a remarkable milestone: 35 years of consistent and innovative听nitinol听melting and processing. From its roots in the early commercialization of shape-memory alloys to today鈥檚 fully integrated, melt-to-device nitinol platform, 91快活林 has played a pivotal role in shaping the capabilities and global adoption of this unique material. The journey began in 1990, when our New Hartford, NY facility started commercially supplying today鈥檚 established VIM/VAR nitinol ingot.听听听

Raychem to Memry: A strategic transfer of innovation

Raychem Corp. was a pioneer in the development of shape-memory alloys for industrial and aerospace applications, including one of the earliest uses of nitinol. But in 1996, Raychem sought to divest its nitinol business, seeing more immediate returns in its core electronics and polymer technologies.听

Memry Corp. seized this opportunity and acquired Raychem鈥檚 shape-memory alloy business, including key intellectual property, and at the time, a state-of-the-art processing plant in Menlo Park, California. This acquisition enabled Memry to pivot from manufacturing finished devices to becoming a vertically integrated supplier of nitinol wire, tubing, and components for the burgeoning medical device industry.听

At the time, Memry was a small company with fewer than 20 employees. The Raychem acquisition was well-timed and marked an important inflection point. Soon after the acquisition, the demand of nitinol wire increased significantly due to the specialized processing and the emergence of new, high-value medical applications.听听

Memry quickly became a trusted supplier to medical device innovators focused on stents, guidewires, filters, and minimally invasive implants.听听

91快活林: From precision laser processing to melt-to-device leadership

While Memry was scaling its nitinol supply chain across California and Connecticut, 91快活林 (founded in 1987) was carving out its niche in precision laser micromachining for medical devices. Over the next 30 years, the company rapidly broadened its capabilities, adding laser ablation, centerless grinding, microfluidics, and complex component manufacturing to its portfolio. Though it began processing nitinol components, 91快活林 was already laying the groundwork for a more ambitious goal: delivering a fully integrated nitinol solution.听

That ambition came to fruition in 2023 when听. This acquisition instantly transformed 91快活林 into the only vertically integrated nitinol manufacturer with in-house capabilities spanning melting, alloy development, sheet, tube and wire drawing, laser processing, EDM, shaping, electropolishing, and finishing.听

With nitinol facilities now across Connecticut, California, New York, New Hampshire, Minnesota, Costa Rica, and Israel, 91快活林 can support customer needs from early-stage prototyping to high-volume production, all within the same company!听听

Serving the full spectrum of the market

Today, 91快活林 serves a global customer base ranging from nimble startups to the largest OEMs in the medical device industry. The company is unique in its ability to support:听

• Custom Alloy Melting:听Binary, ternary, and quaternary nitinol compositions.听

• Raw Material Forms:听Bar, ingot, tube, sheet, and wire.听

• Component Manufacturing:听Laser-cut tubes, precision ground wires, shaped devices, braided structures.听

• R&D and Prototyping:听Lightspeed Labs locations for rapid innovation.听

• Scale-Up:听High-capacity tubing and wire lines for commercial volumes.听

• Lead-Time Optimization:听Internal supply chain coordination for faster turnaround.听

Importantly, 91快活林 also openly supplies melt material to other raw material and component suppliers, reinforcing its position as an enabler across the industry rather than a closed-loop competitor.听听听

Looking ahead: Innovation through integration

As the medical device industry continues to demand smaller, smarter, and more resilient implants, nitinol continues to play a significant role. Its combination of elasticity, fatigue resistance, and biocompatibility make it needed in many applications.听

91快活林 is committed to pushing the boundaries of what nitinol can do, developing tighter tolerances, more complex geometries, and advanced metallurgies that enable next-generation therapies. This commitment is backed by decades of accumulated IP, cross-disciplinary engineering teams, and a strong focus on customer success.听

A legacy of leadership

Thirty-five years after our first commercial sales of nitinol ingot material, and nearly four decades since 91快活林鈥� founding, the company is now the global standard-bearer for nitinol processing. 91快活林 has not only preserved the original innovation but has amplified it, building a robust, scalable, and agile platform that serves the entire nitinol market.听

With the industry鈥檚 most comprehensive capabilities and a legacy rooted in technical excellence, 91快活林 is poised to lead the nitinol market into its next era of growth and innovation.

The post 91快活林 Celebrates 35 Years of Consistent Nitinol Melting and Processing appeared first on Driving Innovation in MedTech & Life Sciences.

The unique metal offers novel capabilities that make it ideal for new innovations and specialized applications that benefit from its properties.

Originally featured in  on May 22, 2025.

When developing a device, material selection is a critical early step. In an ideal situation, a new product will gain advantages from the inherent properties provided by the choice of metal, plastic, ceramic, or whatever option is chosen. As such, it鈥檚 important to be familiar with the potential alternatives available that would make the best match for the device.

Unfortunately, not all materials are commonly used and there鈥檚 a lack of familiarity with them. For example, Nitinol is a metal that isn鈥檛 often selected for many orthopedic applications, however, it provides a unique set of properties that would make it ideally suited for specific situations. With this in mind, it鈥檚 vital to work with an expert on the metal or material, such as Nitinol, you are considering.

Fortunately, a representative from 91快活林, a Nitinol expert, took time to respond to questions about the material. In the following Q&A, Eric Veit, Vice President, Nitinol Business Development, addressed what makes Nitinol unique, what orthopedic applications it鈥檚 ideal for, and what manufacturers need to keep in mind when using it (or whether they should be using it).

Sean Fenske: What is Nitinol? What makes it a unique metal?

Eric Veit: Nitinol is a metal alloy composed of nickel (Ni) and titanium (Ti). The name itself is derived from the Nickel Titanium Naval Ordnance Laboratory, where it was first developed in the 1960s. Nitinol is a shape memory alloy (SMA) with two extraordinary properties that set it apart from most metals: shape memory effect and superelasticity (also called pseudoelasticity).

Shape memory effect is a thermally induced phase transformation. Nitinol must be in its martensitic phase to exhibit the shape memory effect. Superelasticity is a stress-induced phase transformation. Both phenomena arise from the same underlying material property, the martensitic phase transformation, but they occur under different conditions. The superelastic property, allowing the metal to 鈥渟pring back to its shape,鈥� is the property most Nitinol devices take advantage of, but they are often confused.

Fenske: What鈥檚 the confusion involving these properties?

Veit: Both properties involve recoverable deformation. In both cases, Nitinol appears to “remember” its shape and return to it after deformation. This can make it difficult to distinguish when one mechanism is at play versus the other.

They each present with the same phase transformation, but these occur due to different triggers. Both behaviors rely on the reversible transformation between austenite (i.e., high-temperature phase) and martensite (i.e., low-temperature phase).

The key difference is how the phase change is triggered. Superelasticity occurs due to mechanical stress, while shape memory occurs due to temperature changes. Some Nitinol devices utilize both properties, making it unclear which mechanism is responsible at a given time. For example, a self-expanding stent uses superelasticity to recover its shape when deployed in a blood vessel, but during manufacturing, shape memory may be used to set its form.

Fenske: What physical properties does Nitinol offer that make it suitable for certain orthopedic applications?

Veit: The super elastic property of nitinol allows it to absorb significant amounts of strain without permanent deformation, making it ideal for devices that need to withstand mechanical stresses, such as stents and bone anchors. The following table lists some of the advantages of Nitinol over other common orthopedic metals鈥攖itanium and stainless steel.

Fenske: Where is Nitinol being used in orthopedic implants? Why?

Veit: Nitinol’s compatibility with the human body, coupled with its corrosion resistance, adds to its appeal for use in orthopedic implants such as bone staples or as a durable material for bone drills or reaming devices. In orthopedic applications, nitinol devices can apply constant force to bones and joints to aid in correction or healing, while in cardiovascular applications, nitinol stents can adapt to the movements of blood vessels, providing support without causing damage or irritation.

Bone staples used primarily in foot and ankle surgery are, by far, the most common application of Nitinol in the orthopedic space. Bone staples are used to a much lesser degree in hand surgery and spinal surgery. Other orthopedic Nitinol uses include fracture fixation devices, suture anchors, shape-memory plates for bone realignment, and potentially orthodontic (maxillofacial) implants. Beyond implants, the flexibility and shape memory can be advantageous for delivery systems as well.

Fenske: For what types of instrumentation in orthopedics is Nitinol being used? Why?

Veit: Bone drills and dental drills are types of instrumentation using Nitinol because it can withstand high amounts of strain without breaking.

Nitinol retractors and tissue spreaders are self-expanding and can hold soft tissue apart during surgery. The superelasticity allows flexibility and resilience, reducing the need for mechanical locking or adjustment.

Arthroscopic instruments, such as graspers, probes, or shavers that must pass through narrow joint spaces, benefit from Nitinol鈥檚 torqueability and kink resistance, which make it ideal for tools used in constrained environments.

Nitinol is also used more and more in robotic surgery because the ability to bend and the shape memory effect enable deployment or correction once inside the body, especially with robotic or endoscopic approaches.

Nitinol guidewires and alignment jigs are used to guide drilling or screw placement in trauma and reconstructive procedures because the superelasticity and recoverable deformation are ideal for curved trajectories in bones.

Core benefits using Nitinol for Instrumentation:

路 Self-actuation (via temperature change or pre-stressing)

路 Flexibility and fatigue resistance

路 Reduced need for mechanical parts

路 Improved minimally invasive capabilities

Fenske: What are the important considerations to keep in mind when selecting Nitinol for an orthopedic application? Are there reasons or situations for which it shouldn鈥檛 be used?

Veit: Since most orthopedic applications are bone staples, they typically start from a very different material form than most interventional applications, which start from a Nitinol tube or sheet. A block of Nitinol is milled or machined to create the 3D shape of the staple. There are not very many places in the world that offer the material form needed for this application, but 91快活林 is one of them. Processing these blocks of material can change their mechanical properties if not performed correctly. The result could be two parts that look identical visually and dimensionally but perform completely differently. That is true for all Nitinol; the complexity of the material means it is easy to change the properties at each processing step so process control and material know-how are critical to repeatable results.

As far as situations where it should not be used, it is typically more expensive than other metals. Nitinol is significantly more expensive than stainless and slightly more expensive than titanium, so the use case has to justify the additional cost. If the application will not require flexibility or fatigue, and the application works with other materials, Nitinol should not be used.

Fenske: What aspects are often overlooked when a company is selecting Nitinol (or perhaps with material/metal selection in general) for orthopedic devices?

Veit: When selecting Nitinol (or any material) for orthopedic devices, companies often focus on the headline benefits (e.g., shape memory, superelasticity, biocompatibility), but several critical aspects are frequently overlooked, especially in the context of manufacturability, regulatory compliance, and long-term performance.

路 Processing Sensitivity of Nitinol鈥擜s mentioned earlier, Nitinol is highly dependent on precise processing, especially at the heat treatment steps. Poor control can lead to loss of desired transformation temperatures, poor fatigue performance, or inconsistent device behavior.

路 Fatigue and Fracture Behavior鈥擶hile in theory, Nitinol has high fatigue resistance, in practice, it can suffer from microscopic inclusions, cracking, or surface defects that reduce fatigue. This can lead to premature failure under cyclic loading if not properly processed and inspected.

路 Joining and Machining Challenges鈥擭itinol is very difficult to laser weld, braze, or machine compared to stainless steel or titanium. It鈥檚 super hard on tooling and, therefore, can dramatically affect yield, cost, and design flexibility, especially when complex shapes or tight tolerances are needed.

路 Surface Chemistry and Finishing鈥擲urface oxides created during processing and nickel leaching are concerns that can affect biocompatibility and corrosion performance. Improper surface treatment (e.g., electropolishing, passivation, or coating) can trigger regulatory flags or lead to inflammatory responses.

路 Design for Shape Memory vs. Superelasticity鈥擜s already mentioned, these concepts are often confused, and designers often mix the two properties, but they require different engineering approaches.

路 Cost and Supply Chain Complexity鈥擭itinol is more expensive and has fewer high-precision suppliers globally, so choosing a vertically integrated supplier with deep technical capabilities, like 91快活林, will ensure consistent supply, shorter lead times, and flexible order quantities.

路 Regulatory Scrutiny and Validation鈥擭itinol devices may face stricter validation for fatigue life, nickel release, and thermal performance compared to traditional metals, especially if used in a novel application. The FDA has a guidance document specifically covering Nitinol. You need a supplier that can anticipate these to reduce delayed FDA or CE approvals and help minimize increased test costs.

Fenske: Do you have any additional comments you鈥檇 like to share based on any of the topics we discussed or something you鈥檇 like to tell orthopedic device manufacturers?

Veit: The smartest use of Nitinol isn鈥檛 where it replaces traditional metals, it鈥檚 where it enables new procedures, instruments, or therapies that weren鈥檛 possible before. The opportunity exists for novel applications using Nitinol that exceed the norms of traditionally stainless or titanium applications. I urge companies to explore what they might be able to accomplish with Nitinol either as an implant or perhaps as a delivery system component. We have the expertise to help bring your concept from a napkin sketch to production. Variability in heat treatment, surface finish, or raw Nitinol quality can cause dramatic shifts in device behavior. Work only with experienced Nitinol suppliers and validate every step in the process, from ingot to final form.

The post The Benefits of Nitinol for Orthopedic Devices: Q&A with Eric Veit appeared first on Driving Innovation in MedTech & Life Sciences.

The post Nitinol Post-Shape-Setting TTT & TTS Properties appeared first on Driving Innovation in MedTech & Life Sciences.

Among the most exciting developments? Nitinol鈥攁 shape-memory alloy with properties unlike anything else in the orthopedic toolkit.

Below, we鈥檒l explore what makes nitinol such a compelling material for orthopedic implants, how it’s being used today, and where new research and innovations are taking it next.

Related: The Ultimate Guide to Micro Manufacturing in MedTech and Life Sciences

How Nitinol is Used in Orthopedics

Nitinol isn鈥檛 new. It was originally discovered in 1959, but its shape memory property wasn鈥檛 identified until 1961 during a lab meeting at the U.S. Naval Ordnance Laboratory. Since that discovery, its role in orthopedics has expanded dramatically.

Its shape memory and superelasticity allow implants to apply continuous, adaptive pressure as bones heal, offering advantages over traditional rigid metal hardware.听

As a result, it鈥檚 become indispensable in modern procedures that require continuous compression, flexibility, and long-term durability. This includes the following examples:

• Compression Staples 鈥� Common in foot and ankle procedures, these staples maintain consistent compression across fracture or fusion sites, even if the bone settles or shifts. Compared to screws, they鈥檙e faster to apply and can reduce surgical time while supporting more stable healing.
• Bone Plates and Patellar Claws 鈥� Nitinol plates flex with the body and match the stiffness of cortical bone. That flexibility helps reduce stress shielding and improves long-term outcomes.
• Spinal Implants 鈥� In the spine, nitinol components can compress and expand in place, reducing trauma during insertion while delivering reliable fixation. Its fatigue resistance also makes it well-suited to high-load areas.

Across these applications, the throughline is mechanical intelligence: devices that respond to the body鈥檚 movement rather than resist it.

Related: Nitinol Application in Medical Technology: Q&A with Eric Veit

Advantages of Using Nitinol for Orthopedic Implants

What makes nitinol stand out isn鈥檛 just one property鈥攊t鈥檚 the way multiple advantages come together to solve long-standing orthopedic challenges.

Shape Memory for Smarter Fixation

Once implanted, nitinol can return to its original shape with precise force, helping maintain continuous compression across bone surfaces. This is especially valuable in fractures or fusions, where consistent pressure promotes healing and reduces the risk of gaps forming post-surgery.

Superelasticity That Moves with the Body

Nitinol can flex and rebound under stress without permanent deformation, unlike traditional stainless steel or titanium.听

This means it holds up better under repetitive movement, making it ideal for load-bearing areas like the foot, ankle, and spine. Even if the surrounding bone resorbs slightly, nitinol staples can maintain stable fixation.

Biocompatibility and Corrosion Resistance

Nitinol鈥檚 composition makes it well tolerated by the body, minimizing inflammatory responses and long-term complications. It also resists corrosion in the body鈥檚 internal environment, offering long-lasting, reliable durability.

Reduced Surgery Time and Minimally Invasive Potential

Compression staples made from nitinol are often easier and faster to place than traditional screws, which may reduce operating time. Their design also supports smaller incisions and faster recovery, both major benefits in minimally invasive orthopedic procedures.

Closer Match to Cortical Bone Mechanics

Unlike rigid metals, nitinol鈥檚 mechanical characteristics more closely resemble human cortical bone. This means less stress shielding and more natural load distribution, which may contribute to better long-term outcomes.

How Nitinol鈥檚 Use in Orthopedics is Expanding

Nitinol鈥檚 role in orthopedics is growing, not only for its effectiveness but also for its ability to enable solutions beyond the capabilities of conventional metals.

One area of exciting development: the potential for porous nitinol implants, which offer excellent biocompatibility and can integrate more naturally with bone tissue. The the first implant of this kind produced via combustion synthesis, with promising early feedback on both performance and recovery.听

Researchers are also exploring how nitinol might , where adaptability and precision are critical. Devices that can expand or contract inside the body with minimal trauma could help treat conditions like aneurysms and strokes more effectively than current solutions.

And of course, innovations aren鈥檛 happening in a vacuum. At 91快活林鈥� Bethel-based LightSpeed Lab鈥攖he company鈥檚 orthopedic center of excellence鈥攅ngineers and medical device designers are prototyping, testing, and refining next-gen nitinol solutions.听

As this technology evolves, expect to see nitinol show up in more places: smaller incisions, faster recoveries, and smarter devices that move with the body鈥攏ot against it.

Drive Orthopedic Innovation With 91快活林

Innovation in orthopedic implants from fracture fixation to minimally invasive spine procedures. As research and manufacturing capabilities continue to expand, new possibilities for device development are emerging.

91快活林 is at the forefront of that evolution. With over 30 years as a global leader for MedTech, coupled with our nitinol-focused LightSpeed Lab team鈥攚e鈥檙e there to support end-to-end nitinol development and manufacturing needs.听

To learn more about nitinol and how it鈥檚 being used in next-generation devices, download our Introduction to Nitinol whitepaper.

Have a specific project in mind? Get in touch with our team today to start a conversation.

The post The Use of Nitinol in Orthopedic Implants: Trends and Future Applications appeared first on Driving Innovation in MedTech & Life Sciences.

The post DeviceTalks Webinar: How to Get the Most Out of Nitinol for Your Medical Device Application appeared first on Driving Innovation in MedTech & Life Sciences.